Literature DB >> 7662909

Altered serotonin transporter sites in Alzheimer's disease raphe and hippocampus.

S M Tejani-Butt1, J Yang, A C Pawlyk.   

Abstract

This study measured serotonin transporter (5-HTT) sites in the dorsal raphe nucleus (DRN) and hippocampus in Alzheimer's disease (AD). 5-HTT sites were significantly decreased in the DRN in AD, with significant reductions occurring in the lateral wings of the DRN complex. A significant reduction in 5-HTT sites were also observed in the CA2 subfield of the hippocampus and in the entorhinal cortex in AD. The results indicate that the integrity of 5-HT neurons in the DRN may be compromised in AD, and that region specific alterations in 5-HTT sites may occur in the hippocampal complex in AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662909     DOI: 10.1097/00001756-199505300-00033

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

1.  Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.

Authors:  Mitchell K P Lai; Shirley W Tsang; Margaret M Esiri; Paul T Francis; Peter T-H Wong; Christopher P Chen
Journal:  Psychopharmacology (Berl)       Date:  2010-07-13       Impact factor: 4.530

2.  Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.

Authors:  Kjell Erlandsson; Tharani Sivananthan; Dominic Lui; Andrea Spezzi; Caroline E Townsend; Song Mu; Richard Lucas; Steven Warrington; Peter J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-26       Impact factor: 9.236

3.  Potent depression of stimulus evoked field potential responses in the medial entorhinal cortex by serotonin.

Authors:  D Schmitz; T Gloveli; R M Empson; U Heinemann
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Serotonin reduces synaptic excitation in the superficial medial entorhinal cortex of the rat via a presynaptic mechanism.

Authors:  D Schmitz; T Gloveli; R M Empson; A Draguhn; U Heinemann
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

5.  Molecular imaging of serotonin degeneration in mild cognitive impairment.

Authors:  Gwenn S Smith; Frederick S Barrett; Jin Hui Joo; Najlla Nassery; Alena Savonenko; Devin J Sodums; Christopher M Marano; Cynthia A Munro; Jason Brandt; Michael A Kraut; Yun Zhou; Dean F Wong; Clifford I Workman
Journal:  Neurobiol Dis       Date:  2017-05-13       Impact factor: 5.996

Review 6.  How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.

Authors:  Cynthia L Bethea; Arubala P Reddy; Fernanda Lima Christian
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Serotonergic modulation of Neural activities in the entorhinal cortex.

Authors:  Saobo Lei
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

Review 8.  Protective actions of ovarian hormones in the serotonin system of macaques.

Authors:  Cynthia L Bethea; Arubala P Reddy; Yukari Tokuyama; Jessica A Henderson; Fernanda B Lima
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

9.  Neuroprotective actions of ovarian hormones without insult in the raphe region of rhesus macaques.

Authors:  Y Tokuyama; A P Reddy; C L Bethea
Journal:  Neuroscience       Date:  2008-04-03       Impact factor: 3.590

10.  Ovarian steroids decrease DNA fragmentation in the serotonin neurons of non-injured rhesus macaques.

Authors:  F B Lima; C L Bethea
Journal:  Mol Psychiatry       Date:  2009-10-13       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.